Login

Viorel Panait on the Evolution of Romanian-Ukrainian Collaboration and the Perspectives of Constanta Port | Panait Viorel - CEO of Comvex 00:10:00

Share On Facebook Share On Twitter

Panait Viorel is the CEO of Comvex Constanta.

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Helps the daring build legendary companies from idea to IPO and beyond|George Robson,Partner,Sequoia Capital
00:10:00
Strategies for Managing Risk and Return in Private Equity | John Connaughton, Co-Managing Partner , Bain Capital .
00:10:00
Enhancing Mining Industry Appeal: Embracing Technology to Attract Talent and Investment
00:10:00
Meet Michelle: From Math Major to Developer to Vanguard Scrum Lead - A Journey of Growth and Innovation
00:10:00
Perspectives on Renewable Energy and Nuclear Power | Sébastien Clerc, CEO, Voltalia SA.
00:10:00
The information provided is solely for institutional use, serving as informational material on Mesirow investment vehicles, subject to the appropriate Offering Memorandum for investment decisions.
00:10:00
Discussion Group CAP | NICOLÁS BURR G., CHIEF EXECUTIVE OFFICER, CAP SA
00:10:00
we are focused on the real estate technology industry|Aaron Block,Managing PartnerMetaProp
00:10:00
Morgans adviser Chris Titley recently chatted with Alex Waislitz, founder and Chairman of Thorney Technologies Ltd, about Skyfii Limited.
00:10:00
Apollo's Strategy on Talent Acquisition: Insights from Managing Director Jonathan Simon
00:10:00
Electrica SA's General Manager Corina Popescu to Go Undercover in Her Own Company | Georgeta Corina Popescu, CEO , Societatea Energetica Electrica SA.
00:00:00
Gary Phillips, CEO of Australian biopharma company, Pharmaxis Ltd, discusses ensuring continuity of supply of its products - Gary Phillips, CEO, Pharmaxis Ltd

© 2026 Nehu